✦ LIBER ✦

Development of an Oral Formulation for Oestrone 3-O-Sulphamate, a Potent Sulphatase Inhibitor

✍ Scribed by ULRIKE G. SAHM; GARY J. WILLIAMS; ATUL PUROHIT; M. ISABEL HIDALGO ARAGONES; DAVID PARISH; MICHAEL J. REED; BARRY V. L. POTTER; COLIN W. POUTON

Book ID: 118109940
Publisher: Pharmaceutical Press
Year: 1996
Tongue: English
Weight: 433 KB
Volume: 2
Category: Article
ISSN: 2042-7158
DOI: 10.1111/j.2042-7158.1996.tb00524.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The development of A-ring modified analo

The development of A-ring modified analogues of oestrone-3-O-sulphamate as potent steroid sulphatase inhibitors with reduced oestrogenicity

✍ A. Purohit; K.A. Vernon; A.E. Wagenaar Hummelinck; L.W.L. Woo; H.A.M. Hejaz; B.V 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 206 KB

A-ring analogues of oestrone 3-O-sulpham

A-ring analogues of oestrone 3-O-sulphamate as potent steroid sulphatase inhibitors and potential anti-cancer agents

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 128 KB

X-ray Crystal Structure and Mechanism of

X-ray Crystal Structure and Mechanism of Action of Oestrone 3-O-Sulphamate, a Synthetic Active Site-directed Inhibitor of Oestrone Sulphatase

✍ GARY J. WILLIAMS; L. W. LAWRENCE WOO; MARY F. MAHON; ATUL PUROHIT; MICHAEL J. RE 📂 Article 📅 1996 🏛 Pharmaceutical Press 🌐 English ⚖ 499 KB

Development of an Oral Drug Formulation

Development of an Oral Drug Formulation for Dichloroacetate and Thiamine

✍ Henderson, George N.; Whalen, Patrick O.; Darr, Rebecca A.; Curry, Stephen H.; D 📂 Article 📅 1994 🏛 Informa plc 🌐 English ⚖ 618 KB

750 Preclinical characteristics of ITMN-

750 Preclinical characteristics of ITMN-B, an orally active inhibitor of the HCV NS3/4A protease nominated for preclinical development

✍ S.D. Seiwert; S.W. Andrews; H. Tan; T. Wang; B. Marafino; R. Rieger; J. Pheneger 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 58 KB